Balyasny Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$2.66M Buy
2024
Q4
$624K Buy
2024
Q3
Sell
2024
Q2
$9.52M Buy
2023
Q3
Sell
2023
Q2
$160K Buy
2023
Q1
$102K Sell
2022
Q4
$164K Buy